Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
CRH
CRH
|
+$150M |
| 2 |
Kenvue
KVUE
|
+$98.9M |
| 3 |
Textron
TXT
|
+$50.7M |
| 4 |
Extra Space Storage
EXR
|
+$23.3M |
| 5 |
AngloGold Ashanti
AU
|
+$17.1M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.12B |
| 2 |
Microsoft
MSFT
|
+$890M |
| 3 |
Amazon
AMZN
|
+$463M |
| 4 |
NVIDIA
NVDA
|
+$425M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$316M |
Sector Composition
| 1 | Technology | 29.44% |
| 2 | Healthcare | 13.62% |
| 3 | Consumer Discretionary | 11.97% |
| 4 | Industrials | 9.13% |
| 5 | Communication Services | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Enovix
ENVX
$1.77B
| $3.49M | ﹤0.01% |
317,829
+23,315
| +8% | +$256K |
|
1502
Patrick Industries
PATK
$3.67B
| $3.49M | ﹤0.01% |
69,713
| – | – |
|
1503
Enova International
ENVA
$2.88B
| $3.48M | ﹤0.01% |
68,500
| – | – |
|
1504
Tilray
TLRY
$1.23B
| $3.48M | ﹤0.01% |
1,456,738
+24,800
| +2% | +$59.3K |
|
1505
Tronox
TROX
$767M
| $3.47M | ﹤0.01% |
258,500
+6,200
| +2% | +$83.3K |
|
1506
Crinetics Pharmaceuticals
CRNX
$3.2B
| $3.46M | ﹤0.01% |
116,400
+34,200
| +42% | +$1.02M |
|
1507
Sonos
SONO
$1.83B
| $3.46M | ﹤0.01% |
268,000
+4,600
| +2% | +$59.4K |
|
1508
NeoGenomics
NEO
$1.03B
| $3.45M | ﹤0.01% |
280,400
+2,700
| +1% | +$33.2K |
|
|
JWN
1509
DELISTED
Nordstrom
JWN
| $3.45M | ﹤0.01% |
230,800
+4,100
| +2% | +$61.3K |
|
1510
Virtu Financial
VIRT
$3.1B
| $3.44M | ﹤0.01% |
199,300
-3,200
| -2% | -$55.3K |
|
1511
MasterBrand
MBC
$1.71B
| $3.43M | ﹤0.01% |
282,500
+3,300
| +1% | +$40.1K |
|
|
ROIC
1512
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $3.43M | ﹤0.01% |
277,000
+4,800
| +2% | +$59.4K |
|
1513
RLJ Lodging Trust
RLJ
$1.15B
| $3.43M | ﹤0.01% |
349,858
-2,100
| -0.6% | -$20.6K |
|
1514
Beam Therapeutics
BEAM
$2.08B
| $3.42M | ﹤0.01% |
142,400
+16,300
| +13% | +$392K |
|
1515
PROG Holdings
PRG
$1.41B
| $3.42M | ﹤0.01% |
103,000
| – | – |
|
1516
International Seaways
INSW
$2.33B
| $3.38M | ﹤0.01% |
75,200
+300
| +0.4% | +$13.5K |
|
1517
Liberty Live Group Series C
LLYVK
$9.23B
| $3.37M | ﹤0.01% |
+105,046
| New | +$3.37M |
|
|
JBGS
1518
JBG SMITH
JBGS
$1.45B
| $3.37M | ﹤0.01% |
232,758
-3,100
| -1% | -$44.8K |
|
1519
Park National Corp
PRK
$2.72B
| $3.36M | ﹤0.01% |
35,600
+200
| +0.6% | +$18.9K |
|
1520
Clearwater Analytics
CWAN
$5.73B
| $3.35M | ﹤0.01% |
173,000
+1,700
| +1% | +$32.9K |
|
1521
Construction Partners
ROAD
$7.02B
| $3.33M | ﹤0.01% |
91,100
+1,100
| +1% | +$40.2K |
|
1522
Freedom Holding
FRHC
$10.1B
| $3.33M | ﹤0.01% |
39,300
+400
| +1% | +$33.9K |
|
1523
Vericel Corp
VCEL
$1.62B
| $3.33M | ﹤0.01% |
99,300
+1,200
| +1% | +$40.2K |
|
1524
Oxford Industries
OXM
$704M
| $3.33M | ﹤0.01% |
34,600
+200
| +0.6% | +$19.2K |
|
1525
MGP Ingredients
MGPI
$596M
| $3.32M | ﹤0.01% |
31,500
+300
| +1% | +$31.6K |
|